Skip to content

Effects of intestinal microecology and fecal transplantation on metabolic syndrome and its mechanism

Study and Transformation of Standardized Fecal Transplantation for the Treatment of Type 2 Diabetes Mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17011792
Enrollment
Unknown
Registered
2017-06-28
Start date
2017-06-27
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 and 2 Diabetes Mellitus

Interventions

Type 2 diabetes is poorly controlled by oral medication:FMT
Type 2 diabetes has poor control of insulin:FMT

Sponsors

The Second Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Normal: fasting blood glucose 7.0mmol / 1 or DM symptoms plus random venous plasma glucose> = 11.1mmol / 1 or OGTT test 2h> = 11.1mmol / 1 was diagnosed as T2DM patients. (Note: fasting standard: fasting> = 8h: Random blood sugar: do not consider the last fasting time of any time blood glucose; DM symptoms: more Drink, polyuria and weight loss without cause).

Exclusion criteria

Exclusion criteria: Exclude criteria: (1) special types of DM and pregnancy DM; (2) suffering from tumor and liver, kidney and other organs severe loss (3) with other endocrine diseases such as thyroid; (4) taking antibiotics and micro-ecological NN in the past month; (5) Nearly 4 weeks of diarrhea or other gastrointestinal diseases; (6) previous history of gastrointestinal surgery;

Design outcomes

Primary

MeasureTime frame
Serum, feces, gut microbiota;

Countries

China

Contacts

Public ContactDing Dafa

The Second Affiliated Hospital of Nanjing Medical University

dingdafa2004@aliyun.com+86 15850514014

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026